Extraskeletal actions of vitamin D

被引:125
作者
Bikle, Daniel D. [1 ,2 ,3 ]
机构
[1] Vet Affairs Med Ctr, Dept Med, 1700 Owens St,Room 373, San Francisco, CA 94158 USA
[2] Vet Affairs Med Ctr, Dept Dermatol, 1700 Owens St,Room 373, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, 1700 Owens St,Room 373, San Francisco, CA 94158 USA
来源
MARROW 2016, VOL 1376 | 2016年 / 1376卷
关键词
vitamin D; CYP27B1; cancer; cardiovascular; skin; immune system; CALCIUM-SENSING RECEPTOR; TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; HUMAN-COLON-CANCER; 25-HYDROXYVITAMIN D CONCENTRATIONS; TYPE-2; DIABETES-MELLITUS; PLACEBO-CONTROLLED TRIAL; NONMELANOMA SKIN-CANCER; HIGH-DOSE VITAMIN-D-3; 3RD NATIONAL-HEALTH;
D O I
10.1111/nyas.13219
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The vitamin D receptor (VDR) is found in nearly all, if not all, cells in the body. The enzyme that produces the active metabolite of vitamin D and ligand for VDR, namely CYP27B1, likewise is widely expressed in many cells of the body. These observations indicate that the role of vitamin D is not limited to regulation of bone and mineral homeostasis, as important as that is. Rather, the study of its extraskeletal actions has become the major driving force behind the significant increase in research articles on vitamin D published over the past several decades. A great deal of information has accumulated from cell culture studies, in vivo animal studies, and clinical association studies that confirms that extraskeletal effects of vitamin D are truly widespread and substantial. However, randomized, placebo-controlled clinical trials, when done, have by and large not produced the benefits anticipated by the in vitro cell culture and in vivo animal studies. In this review, I will examine the role of vitamin D signaling in a number of extraskeletal tissues and assess the success of translating these findings into treatments of human diseases affecting those extracellular tissues.
引用
收藏
页码:29 / 52
页数:24
相关论文
共 288 条
[31]  
Bikle DD, 2011, DISCOV MED, V11, P7
[32]   TUMOR-NECROSIS-FACTOR-ALPHA REGULATION OF 1,25-DIHYDROXYVITAMIN-D PRODUCTION BY HUMAN KERATINOCYTES [J].
BIKLE, DD ;
PILLAI, S ;
GEE, E ;
HINCENBERGS, M .
ENDOCRINOLOGY, 1991, 129 (01) :33-38
[33]   NEONATAL HUMAN FORESKIN KERATINOCYTES PRODUCE 1,25-DIHYDROXYVITAMIN-D3 [J].
BIKLE, DD ;
NEMANIC, MK ;
WHITNEY, JO ;
ELIAS, PW .
BIOCHEMISTRY, 1986, 25 (07) :1545-1548
[34]   25 hydroxyvitamin D 1 α-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis [J].
Bikle, DD ;
Chang, S ;
Crumrine, D ;
Elalieh, H ;
Man, MQ ;
Choi, EH ;
Dardenne, O ;
Xie, Z ;
St Arnaud, R ;
Feingold, K ;
Elias, PM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (04) :984-992
[35]   REGULATION OF 1,25-DIHYDROXYVITAMIN-D PRODUCTION IN HUMAN KERATINOCYTES BY INTERFERON-GAMMA [J].
BIKLE, DD ;
PILLAI, S ;
GEE, E ;
HINCENBERGS, M .
ENDOCRINOLOGY, 1989, 124 (02) :655-660
[37]   Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials [J].
Bischoff-Ferrari, H. A. ;
Dawson-Hughes, B. ;
Staehelin, H. B. ;
Orav, J. E. ;
Stuck, A. E. ;
Theiler, R. ;
Wong, J. B. ;
Egli, A. ;
Kiel, D. P. ;
Henschkowski, J. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :843
[38]   Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline A Randomized Clinical Trial [J].
Bischoff-Ferrari, Heike A. ;
Dawson-Hughes, Bess ;
Orav, John ;
Staehelin, Hannes B. ;
Meyer, Otto W. ;
Theiler, Robert ;
Dick, Walter ;
Willett, Walter C. ;
Egli, Andreas .
JAMA INTERNAL MEDICINE, 2016, 176 (02) :175-183
[39]  
Bizzarri C, 2010, DIABETES CARE, V33, P1962, DOI [10.2337/dc10-0814, 10.2337/dc10-1168]
[40]   Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey [J].
Black, PN ;
Scragg, R .
CHEST, 2005, 128 (06) :3792-3798